Graham Capital Management, L.P. Harrow Health, Inc. Transaction History
Graham Capital Management, L.P.
- $5.08 Billion
- Q4 2024
A detailed history of Graham Capital Management, L.P. transactions in Harrow Health, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 11,671 shares of HROW stock, worth $337,875. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,671Holding current value
$337,875% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HROW
# of Institutions
184Shares Held
21.1MCall Options Held
679KPut Options Held
1.27M-
Opaleye Management Inc. Boston, MA3.99MShares$116 Million26.33% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$62.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$54.2 Million0.0% of portfolio
-
Private Capital Management, LLC Naples, FL1.69MShares$49.1 Million6.85% of portfolio
-
Braidwell LP Stamford, CT907KShares$26.3 Million1.7% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $784M
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...